Adis Journals
Adis offers a portfolio of over 30 respected medical journals, published by Springer Nature, that deliver trusted, peer-reviewed content across drug development, clinical practice, and health policy.
With high Impact Factors, global readership, and author-friendly processes, our journals are a valued resource for researchers, healthcare professionals, and decision makers.
Adis Journals provide a proven platform for advancing medical knowledge.
Adis Premier Journals
Essential reading for healthcare specialists and researchers with a focus on drugs, devices and other interventions.
Adis Rapid+ Journals
Offer all of the traditional advantages of open access publication, with the addition of rapid publication.
Adis Open Access Journals
Adis publishes a number of Premier and Rapid+ journals that are fully open access. All articles are freely accessible by anyone, anywhere, immediately upon online publication, and you, as the author, retain copyright of your work.
Adis Drug Reviews
The Adis Drug Review program provides readers with the most important and clinically relevant information on the properties of new and established drugs, across all therapeutic areas. These definitive reviews are published in a number of our journals and have been a trusted resource for healthcare practitioners for more than 40 years.
Adis VIP Service
The Adis VIP Service is available for Adis Premier Journals and offers accelerated publication by prior arrangement. Our in-house Adis VIP Service staff will escort you through each step, providing full support to guide your article from submission to publication in just 30 days.


































